US$ 21.05
how long can you take glp-1 Do Know When Semaglutide Is Working? What Is GLP-1 and Why
Description
95% CI 0.89 to 0.44), and WC (SMD 0.40

Group one included patients with moderate PAD who were started on GLP-1 RAs, and group two included patients with moderate PAD who were not started on GLP-1 RAs. At one year, patients with moderate PAD who were started on GLP-1 RAs had fewer major adverse limb events (MALE) (0.8% vs 1.5%), major adverse cardiac events (MACE) (25.4% vs 29.3%), and decreased risk of hospitalizations (17.9 vs 26.8%)

GLP-1 agents have reshaped the management of obesity, and the market continues to accelerate as new agents and indications emerge

Learn how standard titration and microdosing compare and why a licensed provider should guide your dosing plan.

The purpose of this review is two-fold: (1) to discuss a case report of idiopathic intracranial hypertension (IIH) after abrupt cessation of a glucagon-like peptide-1 (GLP-1) receptor agonist with resultant rapid weight gain and (2) to review the ...
Imitation drugs, unexpected benefits, serious pitfallsheres what comes next as GLP-1 medications continue to rise in popularity
